Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Lancet (London, England)"
topic_facet:"Research Support, Non-U.S. Gov't"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&lookfor=%22COVID19%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&lookfor=%22COVID19%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Lancet+%28London%2C+England%29%22&filter%5B%5D=topic_facet%3A%22Research+Support%2C+Non-U.S.+Gov%27t%22&lookfor=%22COVID19%22&type=Subject
PubPharm (60)
1
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC) : an open-label, platform-adaptive randomised controlled trial
enthalten in:
Lancet (London, England)
| 2023
von
Butler, C.
|
Hobbs, F.
|
Gbinigie, O.
| +133
CommentIn: Lancet. 2023 Jan 28;401(10373):250-251. - PMID 36566762
Wird geladen...
2
COVID-19 vaccination uptake for half a million non-EU migrants and refugees in England : a linked retrospective population-based cohort study
enthalten in:
Lancet (London, England)
| 2022
von
Burns, R.
|
Campos-Matos, I.
|
Harron, K.
| +1
Wird geladen...
3
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance : a prospective observational study from the ZOE COVID Study
enthalten in:
Lancet (London, England)
| 2022
von
Menni, C.
|
Valdes, A.
|
Polidori, L.
| +21
Wird geladen...
4
Pandemic preparedness and COVID-19 : an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021
enthalten in:
Lancet (London, England)
| 2022
von
COVID-19 National Preparedness Collaborators
|
Bollyky, T.
|
Hulland, E.
| +83
Wird geladen...
5
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease : results of a systematic review and meta-regression
enthalten in:
Lancet (London, England)
| 2022
von
Feikin, D.
|
Higdon, M.
|
Abu-Raddad, L.
| +11
CommentIn: Lancet. 2022 Mar 5;399(10328):887-889. - PMID 35202602
Wird geladen...
6
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019 : a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
enthalten in:
Lancet (London, England)
| 2022
von
Bravo, L.
|
Smolenov, I.
|
Han, H.
| +44
CommentIn: Lancet. 2022 Jan 29;399(10323):415-417. - PMID 35065704
Wird geladen...
7
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002) : a single-blind, randomised, controlled, phase 2/3 trial
enthalten in:
Lancet (London, England)
| 2021
von
Ramasamy, M.
|
Minassian, A.
|
Ewer, K.
| +162
ErratumIn: Lancet. 2021 Dec 19;396(10267):1978. - PMID 33341142
Wird geladen...
8
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) : interim results of a randomised, double-blind, controlled, phase 3 trial
enthalten in:
Lancet (London, England)
| 2021
von
Ella, R.
|
Reddy, S.
|
Blackwelder, W.
| +106
CommentIn: Lancet. 2021 Dec 11;398(10317):2134-2135. - PMID 34774194
Wird geladen...
9
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA : a retrospective cohort study
enthalten in:
Lancet (London, England)
| 2021
von
Tartof, S.
|
Slezak, J.
|
Fischer, H.
| +12
CommentIn: Lancet. 2021 Oct 16;398(10309):1382-1383. - PMID 34656213
Wird geladen...
10
Considerations in boosting COVID-19 vaccine immune responses
enthalten in:
Lancet (London, England)
| 2021
von
Krause, P.
|
Fleming, T.
|
Peto, R.
| +15
CommentIn: Lancet. 2022 Mar 26;399(10331):1224. - PMID 35339219
Wird geladen...
1
2
3
4
5
6
Nächster »
[6]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Lancet (London, England)
Filter aufheben
Thema: Research Support, Non-U.S. Gov't
Medienart
60
Aufsätze
60
E-Artikel
60
E-Ressourcen
Zeitschriftentitel
Lancet (London, England)
Thema
60
COVID-19 Vaccines
Research Support, Non-U.S. Gov't
43
Journal Article
17
Letter
13
Randomized Controlled Trial
12
B5S3K2V0G8
12
ChAdOx1 nCoV-19
11
BNT162 Vaccine
11
N38TVC63NU
10
Viral Vaccines
9
Antibodies, Viral
8
Antibodies, Neutralizing
8
Clinical Trial, Phase II
8
Multicenter Study
7
Spike Glycoprotein, Coronavirus
5
Clinical Trial, Phase III
5
Comment
5
Immunoglobulin G
4
spike protein, SARS-CoV-2
3
Adjuvants, Immunologic
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2023
5
2022
43
2021
11
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
60
Englisch
Haven't found what you're looking for?
Wird geladen...